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Probiotics and prebiotics are emerging household terms, whose claimed health benefits 
share commonality. Their attributed health benefits include the production or induction of short 
chain fatty acids, maintaining bowel function, building colonization resistance (against 
pathogens) and treating antibiotic-associated diarrhea as well as colitis. Although both probiotic 
and prebiotic effects on immune system have been studied, the mechanisms of their activity are 
still not clearly defined and the conclusions drawn are elusive.  While probiotics can act to 
influence the host at the cellular level, prebiotics, by definition, exert their effects indirectly 
through their impact on gut microbes.  One purpose of this study was to investigate effects of 
Lactobacillus rhamnosus R0011 on innate immune parameters at the intestinal epithelial cell 
level, examining effects on both human and rat IEC.  A second purpose was to define the effects 
of a range of prebiotic dietary fibres on the immune system at the mucosal and systemic level, 
using Biobreeding rats.  
L. rhamnosus demonstrated the ability to decrease proinflammatory cytokine and Toll-
like receptor agonist-induced IL-8 and CINC-1 production from human and rat IEC, 
respectively. The timing of L. rhamnosus R0011 addition to HT-29 IEC, relative to 
proinflammatory challenge, influenced its ability to decrease IL-8 production. L. rhamnosus was 
more effective at decreasing production of IL-8 from human IEC when they were pre-incubated 
with this bacterium and subsequently challenged with proinflammatory stimuli. Certain effects of 
L. rhamnosus R011 were also observed in the absence of proinflammatory stimuli. Viable L. 
rhamnosus induced TNF-α production from rat IEC and heat-killed L. rhamnosus decreased 
constitutive TGF-β production from rat IEC and induced IL-8 or CINC-1 production from 
human and rat IEC, respectively.  
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In Biobreeding rats, we demonstrated that oat dietary fibre significantly alters active 
TGF-β, CINC-1 and IL-6 levels in the colon in comparison to AIN-93G-fed rats. Wheat dietary 
fibre induced changes in active TGF-β, CINC-1 and IL-4 levels in the ileum in comparison to 
resistant starch-fed rats. Lastly, resistant starch exerted effects in the mesenteric lymph node, 
where changes in active TGF-β were observed in rats in comparison to AIN-93G-fed rats.  Oat 
bran, wheat bran and resistant starch had no effects on cytokine levels in the serum or spleen of 
rats. Fructooligosaccharide-fed rats had a significant increase in active TGF-β levels in the colon 
and a significant decrease in active TGF-β levels in the spleen.  Overall this suggests a FOS 
supplemented diet has both mucosal and systemic effects in rats, while wheat, oat and resistant 
starch supplemented diets had effects focused at the different locations at the mucosal level.  
These results illustrate differences in the ability of different dietary fibres to target 
immune parameters in specific mucosal tissues along the gastrointestinal tract and differential 
ability to exert systemic effects.  Understanding the mechanism of action of probiotics provides 
insight into the downstream effects of prebiotics, while investigating effects of prebiotics on the 
immune system provides a broader view of the outcome of changes in gut microbiota 
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Figure 21. Quantification of active TGF-β (pg/g) within the MLN. Rats were fed either AIN-93G 
alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The 
bars represent the mean ± SE (n=4-6). TGF-β was BLQ in the MLN with one AIN-93G and one 
wheat bran-fed rat. These rats were assigned a value of 0 pg/g. There was a significant difference 
observed between rats fed-resistant starch and AIN-93G control diets (p<0.01). Bars with 
different letters are significantly different from each other (as determined by a Kruskal-Wallis 
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Figure 25. Quantification of CINC-1, IL-6, IL-4, IL-10 and active TGF-β (pg/g) within splenic 
tissue. Rats were fed either Purina chow alone or Purina chow supplemented with 5% FOS. The 
bars represent the mean ± SE (n=5-6). Both IL-4 and IL-6 cytokine levels were BLQ. There was 
no significance effect on CINC-1 and IL-6 levels between rats fed the different diets, as 
measured by a t-test. There was a significant difference in  between rats fed Purina chow and rats 
fed the 5% FOS diet (p<0.05). Bars with asterisks denote significance (as determined by a 
Student’s t-test). 
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tissue. Rats were fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% 
wheat fibre or 5% resistant starch. The bars represent the mean ± SE (n=5-6). IL-10 cytokine 
levels were BLQ. IL-4 was BLQ in the splenic tissue of one oat bran-fed rat. This rat was 
assigned a value of 0 pg/g. There was no significant effect of diet on any cytokine levels, as 
determined by an ANOVA and a Kruskal-Wallis test (for IL-4 values). 
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fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=5-6). There was no significant effect of 
diet, as determined by an ANOVA.  
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alone or supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean and ± SE (n=5-6). Those rats that are 0 pg/g represent IL-2 in rats that were 
BLQ. There was no significant effect of diet, as determined by a Kruskal-Wallis test and Dunn 
post-hoc test.  
 
Figure 30. Quantification of CINC-1, IL-6, IL-4 and active TGF-β (pg/g) within the ileal tissue. 
Rats were fed either Purina chow or Purina chow supplemented with 5% FOS. The bars 
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of the diets on any cytokine level. Bars with asterisks denote significance (as determined by a 
Student’s t-test). 
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± SE (n=6). There was no significance observed between the diets, as determined by a Student’s 
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no significance effect of diet, as determined by a Student’s t-test.  
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resistant starch. The bars represent the mean ± SE (n=4-8). There was a significant difference in 
CINC-1 levels between rats fed  5% wheat fibre and 5% resistant starch diets (p<0.01). IL-4 was 
BLQ in the ileal tissue for one AIN-93G and one resistant starch-fed rat. These rats were 
assigned a value of 0 pg/g.  There was a significant difference in IL-4 levels  observed between 
rats fed 5% wheat fibre and rats fed 5% resistant starch diets (p<0.01). Active TGF-β was BLQ 
in the ileal tissue of one AIN-93G and one resistant starch-fed rat. These rats were assigned a 
value of 0 pg/g. There were  significant differences observed between rats fed 5% wheat fibre 
and 5% resistant starch diets (p<0.01), 5% oat fibre and 5% resistant starch diets (p<0.05). Bars 
with different letters are significantly different from each other (as determined by a Kruskal-
Wallis test and Dunn post-hoc test). 
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either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=6-8). There was no significant effect of 
diet, as determined by an ANOVA.  
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or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean ± SE (n=4-6). Those data points that were BLQ were assigned a value of 
0pg/g. There was significance observed between 5% wheat-fed rats and 5% resistant starch-fed 
rats (p<0.01). Bars with different letters are significantly different from each other (as 




Figure 36. Quantification of IL-6 (pg/g) within ileal tissue. Rats were fed either AIN-93G alone 
or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean and ± SE (n=4-6). Data points that were BLQ were assigned a value of 0 
pg/g. There was no significance observed between rats fed different diets (as determined by a 
Kruskal-Wallis test and Dunn post-hoc test).  
 
Figure 37. Quantification of CINC-1, IL-6, IL-4, IL-10 and active TGF-β (pg/g) in colonic 
tissue. Rats were fed either Purina chow or Purina chow supplemented with 5% FOS. The bars 
represent the mean ± SE (n=3-7). There was no significant difference in CINC-1, IL-6, IL-4 and 
IL-10 levels between rats fed different diets. There was a significant difference in active TGF-β 
between rats fed Purina chow and rats fed the 5% FOS diet (p<0.05). Bars with asterisks denote 
significance (as determined by a Student’s t-test). 
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colonic tissue. Rats were fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 
5% wheat fibre or 5% resistant starch. The bars represent the mean ± SE (n=3-8). There was a 
significant difference in CINC-1 levels  between rats fed 5% oat fibre and 5% resistant starch 
diets (p<0.05). There was a significant difference observed between rats fed 5% oat fibre and rats 
fed AIN-93G diets (p<0.01), 5% resistant starch and AIN-93G (p<0.01) and 5% oat fibre and 5% 
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wheat fibre diets (p<0.05). There was no significant difference in IL-4 and IL-10 levels between 
rats fed different diets. There was a significant difference in active TGF-β levels between rats fed 
5% oat fibre and rats fed AIN-93G diets (p<0.05). Bars with different letters are significantly 
different from each other (as determined by ANOVA and Bonferroni post-hoc test). 
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fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=3-6). There was no significant effect of 
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The Gut Microbiota 
The gut microbiota is a complex community of thousands of organisms harbored within 
the human intestinal tract. There are about 500-1000 species of bacteria within the gut 
microbiota, contributing to a total population of about 10
13
 bacterial cells, greater than the 
number of cells comprising the human body. The most common species cultured from the human 
GI tract include Escherichia coli, Klebsiella, Streptococcus, Lactobacillus, Staphylococcus, 
Bacillus, Bifidobacterium, Fusobacterium, Clostridium, Eubacterium, Peptococcus and 
Peptostreptoccus [1].  Both anaerobes and aerobes are present within the complex gut niche, but 
anaerobes greatly outnumber the amount of aerobes by about 100-1000 fold [2].While there are 
currently varied theories about and much research into how these bacteria interact with the host, 
the mechanisms behind the introduction and colonization of the gut by bacteria during 
development are not currently fully understood.  
The relationship between the host organism and the gut microbiota is a mutualistic and 
symbiotic one, suggesting that both the microbiota and the intestinal epithelial cells (IEC) that 
come in contact with these bacteria co-evolved [3]. The microbes present benefit from a constant 
supply of nutrients, while the host benefits from the bacteria’s ability to degrade and metabolize 
large macromolecules into products that their body can absorb and metabolize [4] .The 
fermentation accomplished by bacteria produces vital nutrients that are absorbed by the intestinal 
epithelial cells (IEC), including vitamins and short chain fatty acids (SCFA)[5]. If these nutrients 
were not present then cell death would likely occur in the intestinal lining, impairing nutrient 
absorption and leading to malnutrition. Bacterial communities within the gastrointestinal (GI) 
tract of humans are reported to vary due to gender, amount of siblings, or whether a person has 
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been delivered via C-section [6]. This suggests that there are a large variety of influences on the 
human GI microbiota, including environmental and hormonal factors. The gut microbiota has 
large influences in maintaining the balance of health and disease within the gastrointestinal tract, 
as well as contributing to the development of the immune system. 
  The gut microbiota not only contributes to nutritional value of ingested foods, but also 
plays a large role in innate and adaptive immunity at mucosal surfaces, such as the intestine. The 
immune system has evolved in a way that allows these commensal bacteria to live in the 
intestine, yet the immune system can still recognize and eliminate pathogens [3]. 
Probiotics and Prebiotics 
Probiotics are bacteria that promote host health by interacting with the intestinal mucosal 
barrier potentially influencing the growth and development of other intestinal microbiota as well 
as contributing to the homeostasis of mucosal immunity [6]. Prebiotics, however, are non-
digestible food stuffs that are fermented by bacteria, producing a wide variety of products that 
may promote health [7].  Prior evidence indicates that probiotics and prebiotics can increase 
resistance to infection and improve immune responses and  immunoregulation. One way in 
which probiotics may create a positive influence on health is through interaction with the IEC of 
the GI tract [6]. Probiotics also have other routes of interaction in the intestine, including contact 
with M cells; Peyers patches (PP) and the mesenteric lymph nodes (MLN). Through 
fermentation of food products, probiotics can be cultivated and consumed by humans providing 
an alternate route of probiotic delivery than the capsule form, in which they are often delivered.  
Probiotic properties have been observed in Lactobacillus and Bifidobacterium species, 
which are the most common genera used in fermentation of food stuffs. Consumption of 
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probiotics has been observed to increase the barrier effect in the intestine as well as decrease 
intestinal inflammation and increase immunoregulatory activity within mucosal associated 
lymphoid tissues (MALT). Lactobacillus rhamnosus GG in particular is an excellent candidate 
for probiotic culture because it contains many qualities needed in order to be implemented into 
the mucosal microbiota; it is found naturally in humans, it has the ability to attach to human IEC 
and colonize within the intestine and it has resistance to acid and bile (which enables it to reach 
the intestine with high viability). When ingested and incorporated into the intestinal microbiota, 
L. rhamnosus GG has been shown to improve the balance of bacteria within the intestine to those 
that are often considered to be health promoting, and produce SCFAs [1]. Due to these properties 
L. rhamnosus GG is now one of the most studied probiotic bacterial strains. 
 In contrast to probiotics, prebiotics are food ingredients, such as dietary fibres, that are 
non-digestible and promote the growth of specific bacteria within the intestinal tract that confer 
health benefits in the host [7].  Prebiotics are sometimes used in medicine as a mean of providing 
SCFA, maintaining bowel function, building colonization resistance (against pathogens) and 
treating antibiotic-associated diarrhea as well as inflammatory bowel disease (colitis) [8]. The 
target bacteria for most prebiotic supplements are Lactobacillus and Bifidobacterium, the genera 
that have shown the greatest probiotic actions. The end products of fermentation ultimately 
provide the host with beneficial nutrients, potentially increasing overall gut health [8]. Most 
prebiotics are dietary fibres consisting of non-starch polysaccharides and lignin [9].  Dietary 
fibre has been linked to an increase in human health, although, the reasoning is not yet well 
understood. What is understood is that when the dietary fibre enters the intestine, it is fermented 
by the gut microbiota creating an array of different SCFAs [10].  
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SCFAs have many physiological effects when absorbed by the intestinal and colonic 
epithelial cells. These include, but are not limited to, increased salt and water uptake, increased 
mineral solubility and a decrease in luminal pH, which has been attributed with inhibiting the 
growth of harmful bacteria. The most common SCFAs are acetic, propionic and butyric acids. 
Butyric acid has been reported to prevent ulcerative colitis, a form of inflammatory bowel 
disease (IBD) in rat models [11] and humans [12] and compiled research suggests butyrate can 
prevent colonic tumors at early stages [13]. Experiments done in gnotobiotic mice (mice that 
have no gut microbiota) with DSS(dextran sulphate)-induced colitis models have demonstrated 
that supplementation with acetate lowers the symptoms of IBD by lowering levels of the colonic 
myeloperoxidase (MPO) and proinflammatory cytokines MIP1α and TNF-α [14]. But most 
importantly, SCFAs can also play a role in the modulation of the mucosal immune system. 
SCFA interact with the IEC by binding to G-protein coupled receptor 43 (GPR43), a critical 
receptor in the innate immune system [15]. There is also evidence that SCFAs interact with 
neutrophils, suggesting that SCFA may act through more than one route to influence actions of 
cells in the immune system. SCFA administration and uptake by IEC have demonstrated the 
ability to relieve certain symptoms of inflammatory bowel disease. Knockout mice, devoid of the 
gene encoding Gpr43 demonstrate increased inflammation in induced models of colitis, arthritis 
and asthma, providing evidence of the major role SCFA play in mucosal immunity [14].  
Butyrate has also been reported to inhibit NF-κB activation and promote IκBα degradation at the 
IEC levels, preventing induction of proinflammatory activity [16]. 
 SCFA production is dependent upon the dietary fibres consumed and the bacteria present 
within the gut microbiota. Two large groups of prebiotics are currently under investigation for 
their influence on gut microbiota and physiological changes in the host, including the alteration 
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of immune responses. These two types of prebiotics include fructans and resistant starch. 
Fructans are naturally occurring oligosaccharides and fructooligosaccharides found in foods such 
as onions, bananas, wheat, oat, artichokes and garlic. Resistant starch is found in raw potatoes 
and unripe foods, such as bananas [8]. Dietary fibres may also play a prebiotic role. Similarly, 
resistant starch, barley β-glucans, raffinose and oligofructose have demonstrated the ability to 
produce butyrate through their fermentation in both in vitro and in vivo (rats) [10]. When the 
fermentative activity of bacteria within the gut is examined in in the presence of prebiotics, 
bacteria from the Bacteroidetes phylum have been observed to produce large quantities of 
acetate and propionate. In comparison, bacteria from the Firmicutes phylum produce mainly 
butyrate [14].  
Previous investigations with prebiotics, specifically oat bran and wheat bran, have 
demonstrated major trends in the alteration of the normal rat microbiota. In a study by Abnous et 
al. (2009), rats were fed either oat bran or wheat bran and their fecal microbiota was examined 
with 16S sequencing to observe changes in gut microbiota diversity relative to rats receiving 
control diet (AIN-93G) [9]. Through cultivation, researchers observed increases in CFUs of 
anaerobic bacteria over 28 days in both oat and wheat bran-fed rats in comparison to rats 
consuming the control diet.  Rats fed the wheat bran diet had higher levels of Lactobacillus 
acidophilus, while oat bran fed rats had higher counts of Bacteroides, enterococci and 
Enterobacter species. The diversity demonstrated by cultivation did not match that observed 
using molecular methods however.   Degrading gradient gel electrophoresis (DGGE) analysis 
demonstrated that by the end of the 28 day feeding trial, the composition of the microbiota 
differed between all diets [9]. Similarly, in a study by Bouhnik et al. human subject’s feces were 
examined after the ingestion of a series of prebiotic foodtypes (short-chain 
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fructooligosaccharides, soybean oligosaccharides, galactooligosaccharides, and type III resistant 
starch) which demonstrated a greater induction of Bifidobacterium spp growth in comparison to 
controls [17]. In an experiment by Dinoto, Achmad et al. (2006), rats were fed both raffinose and 
encapsulated Bifidobacterium breve to observe the effects on the rat cecal microbiota [18]. Rats 
fed raffinose and B. breve as well as rats fed raffinose only had increases in the species B. 
animalis in cecal samples. In comparison, groups just fed B. breve, had no significant changes in 
the gut microbiota [18]. This study suggests that probiotics themselves may not change the 
microbiota to a great extent; instead, prebiotics must be consumed in order to do so. The effects 
of prebiotics on the intestinal microbiota has been well studied, although, much more must be 
done in order to fully understand the mechanisms involved, especially as many of the earlier 
studies relied on culture based methodology to examine the gut microbiota, thus giving an 
incomplete picture. It is also still unknown how prebiotic fibre-induced changes in the gut 
microbiota can impact the immune system of rats and humans. 
Effects of Prebiotics and Probiotics on the Immune System 
Prebiotics not only have the potential to influence the gut microbiota, but they also have 
an effect on the immune system. Certain of the bacterial species induced by prebiotic 
supplementation have been shown to have an effect on both mucosal immunity and systemic 
immunity, as well as innate and adaptive immunity, influencing proinflammatory and regulatory 
immune responses [3]. IEC are the primary cell type exposed to the commensal bacteria of the 
gut. These cells are well equipped with modes of distinguishing commensal bacteria from 
pathogenic bacteria. One way of recognition is through microbial-associated molecular patterns 
(MAMPs) using pattern recognition receptors (PRRs) [3, 6]. Activation of these receptors on 
IEC leads to signal transduction cascades and ultimately the production of cytokines, 
7 
 
chemokines and antimicrobial compounds (defensins). Two examples of PRRs are toll-like 
receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs). These 
receptors are part of the innate immune system, meaning they do not create memory and are not 
very specific. Instead, they are fast acting and recognize an array of molecules. The adaptive 
immune system is made up of cells and molecules that respond more slowly, yet are able to 
produce memory and are more specific. The adaptive immune system is quite finely controlled 
by both T and B cells. Adaptive and innate immunity cross talk by using specific cell mediators 
(cytokines) as well as antigen presenting cells (ex. Dendritic cells) [19]. 
Within the gut reside the gut-associated lymphoid tissues (GALT). These tissues are 
responsible for the recruitment of dendritic cells (DCs), Immunoglobulin A-producing B cells 
and T cells [3]. There are many tissues with immune type characteristics and responsibility 
within the GALT. The PP and the MLN are examples of two tissues that facilitate adaptive 
immune responses. These tissues house both T and B cells, which play a key role in adaptive 
immunity, and also provide an ideal microenvironment for activation of T and B cells by antigen. 
The activated B and T cells leave these tissues via the blood stream and home back to the MALT 
to  enter the lamina propria where they interact with DCs, which sample and display antigens 
sampled from gut bacteria [20].  
The dendritic cells present within the lamina propria are termed CD103
+
 DCs and 
CXCR1
+
DCs [21]. The CD103
+
 dendritic cells are managed by an array of cytokines, including 
Thymic stromal lymphopoietin (TSLP), Transforming Growth Factor-β (TGF-β) and retinoic 
acid [3]. Recently, the ability of probiotic bacteria to differentiate DCs from an immature to a 
regulatory state has been observed. The mechanism behind this interaction begins in the 
intestine; IEC are stimulated by commensal bacteria within the gut, producing TGF-β and TSLP. 
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These cytokines interact with immature dendritic cells housed within the GALT, specifically the 
lamina propria, turning immature DCs into regulatory DCs, as well as controlling activity of TReg 
cells [22] .   
Probiotics have been observed to stimulate differentiation of T helper 1 (TH1), T helper 2 
(TH2) and T helper 17 (TH17) cells and development of regulatory T (TReg) cells (FOXP3
+
). For 
example, the commensal gut bacterium Bacteroides fragilis has shown the ability to differentiate 
T Helper cells into TReg cells, which in turn produce Interleukin 10 (IL-10) TGF-β. [3]. These 
cytokines have regulatory roles within the immune system, often decreasing states of 
inflammation. Some commensal bacteria not only stimulate regulatory cells, they can also 
stimulate mucosal proinflammatory T cell subtypes, such as TH17 cells. Bacteria that induce 
production of such compounds as serum amyloid A protein (SAA) in the ileum (produced in 
response to segmented filamentous bacteria) promote the differentiation of TH17 cells [23]. 
These cells are located within the GALT and have been implicated in an array of inflammatory 
bowel diseases [6]. Induction of TH17 cells leads to the production of such proinflammatory 
cytokines as IL-1β, IL-6 and IL-23[3]. Research by Zaph et al. (2008) demonstrated that TH17 
cell levels are increased in germ free mice [24]. This group provided evidence that gut 
commensal bacteria control the levels of TH17 within the gut, which is inversely proportional to 
IL-25 production. IL-25 expression drives down IL-23 production, subsequently decreasing the 
levels of TH17 cells within the intestine [24].  
Certain probiotics have been observed to shift the balance of the immune system to a 
more TH2 dominated system. TH1 are implicated in protection against pathogens that are 
bacterial, viral or protozoan, whereas TH2 have been shown to protect against helminths and 
ectoparasites [6]. The shift is completed via stimulation of immune cells, such as monocytes, 
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neutrophils and TReg cells, producing such cytokines as IL-12 and the immunoregulatory 
cytokine IL-10,  [22]. In a study by Ezendam et al., rats with an autoimmune disorder termed 
autoimmune encephalomyelitis (EAE) were fed Bifidobacterium animalis, which significantly 
reduced the numbers of eosinophils and lymphocytes in the lungs [25]. This autoimmune 
syndrome, among others, is caused by inappropriate stimulation of the immune system, leading 
to an increased TH1 immune response. Interestingly, B. animalis had no effect on 
immunoglobulin E (IgE), the Ig class associated with allergy, nor on cytokines associated with 
allergy. It was also observed that the probiotics induced a stronger TH2 response- specifically an 
increase in IL-4, IL-5, IL-10 and IL-13 production [25].  
Studies have shown that gnotobiotic mice develop a truncated immune system, implying 
that the intestinal microbiotia is imperative for a fully functioning immune system [3]. 
Specifically these germ free mice lacked a great number of memory T-cells (CD4
+
) in their 
spleen (peripheral to the intestine) and contained less and smaller germinal centers (locations in 
lymph nodes that contain actively proliferating T and B cells). These mice also expressed a TH2-
type profile. 
The effects of the gut microbiota on the systemic or peripheral immune system are not 
yet well documented, although recent investigations by Clarke et al. (2010) suggest that the 
microbiota play a large role in systemic immunity [26]. This study discovered a major role of 
peptidoglycan in innate immunity, showing that this compound primes neutrophils, enhancing 
their ability to destroy certain pathogens, specifically Streptococcus pneumonia and 
Staphylococcus aureus. The mechanism involves the PPR called nucleotide-binding, 
oligomerization domain-containing protein-1(Nod1). NOD1 recognizes meso-diaminopimelic 
acid (mesoDAP). Peptidoglycan is translocated from the gut and is recognized by neutrophils in 
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the bone marrow. This study demonstrated that neutrophil activity was directly correlated with 
peptidoglycan concentrations within the blood [26]. Nod1
-/-
 mice showed much higher signs of 
susceptibility to pneumococcal sepsis, demonstrating Nod1 and the gut microbiota’s critical role 
in the systemic innate immune system [26].  
Another example of the influence of the gut microbiota on the immune system are the 
changes associated with segmented filamentous bacteria (SFB). These bacteria are present within 
the rodent gut, and induce strong IgA responses compared to rodents that lack these bacteria. 
Rodents without SFB also lack mucosal TH17 cells and are unable to control the growth of 
pathogens within their intestine, as shown in models using Citrobacter rodentium infection. This 
suggests that SFB play a critical role in priming or developing mucosal intestinal immunity. SFB 
have also been shown to increase the production of TH1 cells in the mucosal intestinal lymphoid 
tissues by increasing production of IL-12 by DCs. Both T-cell subsets TH1 and TH17 recruit and 
activate phagocyte cell types such as macrophage and neutrophils, which ultimately remove 
pathogenic bacteria [6]. Recently, SFB have also been identified within humans, which will have 
a large impact on the research avenue of the role of SFB within the gut [3]. 
Current research has shown that different sections of the intestine respond differently to 
prebiotics or probiotics. A study by Gaboriau-Routhiau et al. (2009) has shown that in germ-free 
mice colonized with either mouse fecal microbiota or cultivated microbiota, the ileum responds 
most with respect to cytokine production (mRNA expression) compared to the duodenum, cecum 
and colon. Mice that were fed conventional mouse feces experienced significant increases in 
expression of IL-1β, IL-6, TNF-α, INF-γ, IL-17 and IL-10, as well as CD3ε and Foxp3, 
compared to germ free mice. The colon, in contrast, only had significant increases in IL-17 and 
Foxp3 levels in comparison to germ free mice [27]. This research avenue is currently unexplored 
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and further experiments could help create a model of intestinal specific responses influenced by 
probiotics and prebiotics.       
Effect of Probiotics on Toll-like-Receptors 
TLRs are a very important component of the innate immune system. As mentioned 
previously, they contribute to the homeostasic relationship of commensal intestinal bacteria with 
the host and to recognition of pathogens. The TLRs within the gut are a means through which the 
host can observe the presence of the bacteria colonizing the intestine and monitor the population 
of bacteria. They recognize conserved molecules that bacteria express or release, an example 
being lipopolysaccaride (LPS). Once recognized they aid in the release of cytokines that regulate 
the immune response of the GALT [28]. TLRs also have many other important physiological 
roles such as effects on IEC growth, secretion of defensins and downstream IgA production. 
Although they are very important receptors present in the gut, they are also linked to disease. 
Faulty TLR signaling has been linked to colon cancer and inflammatory bowel disease, such as 
Crohn’s and colitis (lack of TLR5) [29].  
The signaling cascade behind TLRs is often controlled by the myeloid differentiation 
primary-response protein 88 (MYD88) pathway. Once TLRs are activated, MYD88 is recruited 
leading to the phosphorylation (by kinases IKKα and IKKβ), ubiquitylation and therefore 
degradation of IκB by 26S proteasomes [30]. IκB acts as an inhibitor of NF-κB, keeping it from 
entering the nucleus. Once IκB is degraded NF-κB is freed, entering the nucleus as a promoter 
for the transcription of proinflammatory cytokines and adhesion molecules [6]. Activation of 
TLRs on both IEC and DCs (CD103
+
) also has greater downstream effects on adaptive immune 
responses, leading to the production of B cell-activating factor (BAFF), a proliferation-inducing 
ligand (APRIL) and IL-4, which promote both T cell dependent and T cell-independent IgA 
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class-switching [3]. Zaph et al. (2007) have demonstrated that knockout mice with deletions in 
the gene encoding IKK-β have great susceptibility to the parasite Trichuris [31]. Normally, an 
infection with Trichuris would induce a TH2 cytokine profile (IL-4, IL-5 and IL-13). But under 
knockout conditions, a TH1 profile is induced, leading to the production of proinflammatory 
cytokines INF-γ, TNF-α and IL-17. This demonstrates the importance of the NF-κB pathway for 
mucosal immune homeostasis [31]. Below is a chart outlining the different types of TLRs and 
the pathogen-associated molecular patterns (PAMPs) they recognize. 
Table 1.  Overview of relevant immune receptors involved in innate recognition. 
Receptor Motif Recognized Comments Reference 
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Probiotic bacteria, when in contact with IEC, often decrease proinflammatory cytokine 
production (IL-8, IL-1β, TNF-α) due to the blocking of NF-κB action, and an increase in barrier 
function. But, certain probiotics have also been shown to decrease apoptosis and to increase β- 
defensin release, heat shock protein (Hsp) production, mucin expression and sIgA [33]. Though 
the actions and outcomes of certain probiotics are known, different species and strains have been 
observed to act through different mechanisms. This includes a decrease in NF-κB activation or 
increase in mediators of MAPK transduction pathways, such as p38 and ERK1/2 leading to a 
decrease in proinflammatory cytokine production and an increase in production of such anti-
inflammatory cytokines as IL-10 [32, 33]. Another theory suggests that common gut bacteria, 
like B. thetaiotaomicron antagonize the activation of NF-κB by enhancing nuclear transport of its 
p65 (RelA) subunit by forming a complex with PPAR-γ. PPAR-γ is responsible for the export of 
this subunit from the nucleus, inhibiting the ability of NF-κB to enter the nucleus to induce 
proinflammatory cytokine expression [30]. It has also been observed that non-pathogenic 
Salmonella inhibit NF-κB by blocking its degradation by protein IκBα [4], limiting NF-κB 
translocation into the nucleus. Many bacteria are able to alter their surface MAMPS to avoid 
recognition by PRRs. They may also alter the transcriptional and posttranscriptional levels of 
PRRs, varying their expression. It is also hypothesized that certain intestinal alkaline 
phosphatases alter the MAMPs of bacteria, so they are not as recognizable by PRRs, limiting the 
extent of the immune response [4].  
Not only have probiotics been observed to modulate the immune response via effects on 
cytokine production, but they have also been observed to influence the degree of expression of 
TLRs. In a study by Vizoso Pinto and Rodriguez Gomez (2009) it was discovered that the 
intestinal cell line HT-29 becomes sensitized to bacteria after pre-exposure to TNF-α [32]. The 
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proinflammatory chemokine IL-8 levels were higher in those cells treated with the TNF-α and 
Lactobacilli than the cells treated with TNF-α alone. The same results were observed when IEC 
were pre-treated with S. typhimurium in order to activate TLRs, and then treated with 
Lactobacilli. IEC pretreated with Lactobacilli then exposed to S. typhimurium had higher IL-8 
expression than cells treated with S. typhimurium alone. In the same study, it was determined that 
exposure to probiotic Lactobacilli (L. rhamnosus GG and L. plantarum), increased mRNA 
expression levels of both TLR2 and TLR9. In comparison, TLR4 mRNA levels in HT-29 cells 
were consistent with baseline controls. Interestingly, this group also showed that Lactobacilli 
increased TLR5 expression, which recognizes flagellin. Lactobacilli species do not contain 
flagellin, which led researchers to believe that these bacteria are influencing TLR transduction 
[32]. 
Different cells within the body express different TLRs based on their location and external 
environment. In addition, some cells types express different TLR levels on their basal and apical 
surface. The reasons pertaining to the presence and absence on certain cell types is not 
understood. However, it is known that TLR expression is highly controlled by the presence and 
absence of certain cytokines. IEC are among a group of cells that have been investigated to 
determine the types of TLRs present and how their expression is controlled. It has been noted 
that INF-γ and TNF induce TLR4, but the observed results are contradictory [32]. Studies have 
shown that TLR expression depends on the location within the intestinal tract. In the colon, 
TLR2 and TLR4 are expressed at low levels, whereas TLR5 is expressed highly. In the small 
intestine TLR3 is highly expressed, although almost all the TLRs are expressed throughout the 




Secreted Immune Altering Bioative Factors from Probiotic Bacterial Strains  
Lactobacillus GG (LGG) has been observed to be effective in treating rotavirus diarrhea 
in infants and children as well as antibiotic-associated diarrhea. This particular strain has also 
demonstrated the ability to protect against such virulent pathogens as Cryptosporidium parvum, 
Helicobacter pylori and Candida in vivo [34]. It has also been associated with anti-carcinogenic 
properties, due to a decrease in colon cancer in treated murine models. In experiments conducted 
by Tao et al. (2006) it was observed that peptides produced by Lactobacillus GG induced the 
production of cytoprotective heat shock proteins in murine IEC [34]. This was determined by 
measuring the activation of the MAPK family, which is involved in signal transduction of many 
immunostimulatory compounds. Tao et al. also attempted to characterize the secreted factor. 
This study demonstrated that the factor is very heat stable, pH sensitive and less than 10kDa. 
However, it was sensitive to proteases (pepsin, trypsin and protease K) suggesting the bioactive 
factor is a protein/peptide [34]. 
In contrast, prior research has indicated that anti-inflammatory molecules released from 
bacteria like Bifidobacterium and lactic acid bacteria are polyamines [35]. It has been 
documented that polyamines have a major role in humans, such as their roles in synthesis and 
stabilization of DNA, RNA and proteins, cell proliferation and differentiation, and the regulation 
of enzyme activity. It is believed that they also have a key role in development and maturation of 
intestinal mucosal tissue. Previously, it has been determined that after consumption of the yogurt 
LKM512 by human volunteers, polyamine concentrations increased in the intestine, indicating 
that perhaps they play a part in the health benefits associated with probiotics, including control of 
intestinal inflammatory responses. In other experiments, it has been observed that polyamines 
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suppress inflammation. For example, it has been documented that the polyamine spermine down 
regulates macrophage activation and therefore inflammation [35].  
In contrast, Silva et al. (1987) concluded that an antimicrobial substance from 
Lactobacillus GG may be of a fatty acid nature. This antimicrobial substance has been observed 
to inhibit growth of other bacteria in the gut microbiota. Cultures of Lactobacillus GG were 
demonstrated to be heat stable, small molecular weight, resistant to proteases and pH sensitive 
indicating that this substance is most likely a short-chain fatty acid [36].  
The probiotic activity of Lactobacillus acidophilus LB has also been investigated in some 
detail and this strain has been shown to be highly antagonistic against Salmonella in vivo and in 
vitro. This bacterium secretes a heat-stable antimicrobial compound into spent culture 
supernatant of LB (LB-SCS). It has been observed that treatment with LB-SCS kills intracellular 
Salmonella.  It has been previously noted that when a pathogen adheres to or attempts to adhere 
to epithelial cells that there is a release of many cytokines. These cytokines include IL-6, -7, -9, -
10 and TNF-α. When infection occurs, there is often the activation of three protein kinases ERK, 
JNK, p38. These signal transduction pathways lead to the activation of NF-κB and AP-1 leading 
to the release of IL-8. As mentioned previously, IL-8 is a chemokine that attracts lymphocytes to 
areas of infection. LB-SCS has been shown to down regulate S. enterica serovar Typhimurium 
SL134 induced IL-8 production from Caco-2 IEC, demonstrating that this unknown bioactive 
factor controls cytokine expression induced by pathogen adhesion to IEC [37]. It was also 
observed that the LB-SCS decreased trans-cellular passage and intracellular growth of S. 
enterica serovar Typhimurium.  The mechanism through which the factor in LB-CFCS acts has 
been investigated and it is believed to damage bacterial membranes, preventing infection. 
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Coconnier-Polter et al. (2005) observed that Salmonella exposed to LB-CFCS lost intracellular 
ATP, resulting in decreased viability [38].  
Lactobacillus species are not the only microorganism that produces probiotic factors that 
influence the host immune response. Saccharomyces boulardii (Sb) is a species of non-
pathogenic yeast. It has been used in the past to treat human gastrointestinal disorders, such as 
antibiotic associated diarrhea and recurrent Clostridium difficile infection [39]. The probiotic 
factor released from Sb and the mechanism through which it interacts with its host is currently 
unknown. Some theories suggest that it competes with pathogens for nutrients; inhibits pathogen 
adhesion, strengthens enterocyte tight junctions, neutralizes bacterial virulence factors and 
enhances the mucosal immune response. Sougioultzis et al. (2006) hypothesized that Sb 
modulates the immune response by the host through effects on NF-kB signaling [39]. Testing the 
effect of Sb culture supernatant (SbS) on IL-8 production by human monocytes and enterocytes 
indicated that SbS inhibited Il-1β and TNF-α induced IL-8 production from HT-29 IEC. SbS was 
also observed to prevent IκBα degradation, reducing NF-κB- DNA binding in IL-1β and LPS-
induced THP-1 IEC. The bioactive factor in SbS was characterized by boiling, lipid extraction, 
density gradient ultra-centrifugation and gel filtration. The results indicated that the factor was 
















Chapter 1: Determining the effects of Lactobacillus rhamnosus R0011 on Inflammatory 
Responses  
Aim of Study: To observe effects and mechanistic action of L. rhamnosus R0011 in the presence 
of proinflammatory compounds on HT-29 IEC. This was primarily done by measuring 
production of IL-8, a proinflammatory cytokine.  
(i) Comparison of Inflammatory Responses Induced by Tumor Necrosis Factor Alpha 
(TNF-α) and Interleukin-1 Beta (IL-1β) and down regulation with Viable and Heat-
killed L. rhamnosus R0011 
Previous investigations into the use of L. rhamnosus R0011 have demonstrated a decrease in 
constitutive inflammatory cytokine production by HT-29s, and this decrease was observed with 
heat-killed R0011[40]. The same has been demonstrated with LPS-induced IL-8 production [41]. 
Therefore, the efficiency of heat-killed and viable R0011 at altering IEC IL-8 production was 
compared, to determine whether L. rhamnosus must be alive in order to have the same efficiency 
at decreasing proinflammatory parameters. 
(ii) Determining effects of probiotic strains on TLR-induced proinflammatory 
cytokine production 
Decreases in TLR agonist-induced IL-8 production would be anticipated if these strains of 
probiotic bacteria were able to down regulate TLR activation and block NF-κB transduction. To 
examine this, the ability of specific Lactobacillus strains to down regulate IL-8 production 
induced by different TLR agonists was compared. As for objective (i), viable L. rhamnosus was 
compared to heat-killed strains in order to understand mechanisms of immune alteration.  
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(iii) Further characterization of immunomodulatory effects of L. rhamnosus using the 
primary rat IEC-6 cell line 
This objective was similar to objective (i), in that the goal was to determine the effects of 
L. rhamnosus R0011 on proinflammatory cytokine production, but used a nontransformed rat 
IEC cell line (IEC-6). IEC-6 IEC were exposed to similar conditions as the HT-29 IEC, in order 
to observe L. rhamnosus’ ability to down regulate CINC-1 production, and to modulate TGF-β 
and TNF-α production.   
Chapter 2: Determining the Impact of Dietary fibre on the immune system of rats 
Aim of Study: To compare mucosal and systemic effects of different dietary fibres on the immune 
system of rats at the level of the intestinal tract by measuring serum antibody levels and 
cytokines in rat tissue. Another aim was to compare effects of dietary fibres on immunological 
biomarker concentration based on location within the intestinal tract.  
(iv) Trial 2: Oat or wheat bran diet effects on antibody levels in rats 
Rats fed both oat and wheat bran developed different microbiota community profiles in their 
gut, as observed by Abnous et al. (2009) [9]. Antibody levels (IgG1 and IGg2a) in the serum 
were measured for comparison of effects of these dietary fibres on systemic antibody production. 
(v) Trial 3: Fructooligosaccharides (FOS) wheat bran, oat bran and resistant starch diet 
effects on antibody levels and cytokine profiles in rats 
Antibody and cytokine levels in rats fed wheat bran, oat bran or resistant starch, were 
quantified. Specifically, IgG1 and IgG2a were measured in the serum. Based on the previous 
investigations it was hypothesize that varied types of dietary fibres would induce a diverse set of 
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bacteria species within different portions of the gastrointestinal tract and therefore have varying 
impacts on the immune system. Therefore, both colon and ileum tissues were compared for TGF-
β (active and total), IL-4, IL-6, IL-10 levels. In the MLN both active and total TGF-β levels were 
measured. For investigations into the systemic effect of the dietary fibres, cytokine profiles were 
measured in the serum and spleen, including serum CINC-1 and splenic TGF-β, CINC-1, IL-4, 
IL-6, IL-10 and IL-2. Several other serum cytokines were assayed however many were below the 















MATERIALS AND METHODS 
Cell Culture 
 The HT-29 human colorectal adenocarcinoma adherent cell line (ATCC # HTB-38) was 
maintained with RPMI 1640 (Sigma, Canada) containing 10% fetal bovine serum (FBS, Sigma, 
Canada), and 0.5 mg/mL gentamicin sulphate (Sigma, Canada), which constituted HT-29 culture 
media. The cells were grown and maintained in 250 mL, 75 cm
2
 tissue culture flasks (Cellstar, 
Greiner Bio-One, Mississagua, Ontario). The HT-29 cells were sub-cultured by first rinsing with 
Phosphate Buffered Saline (PBS), followed by the addition of 2-3 mL of 20% trypsin EDTA 
(Sigma, Canada), and subsequently diluted in HT-29 culture media. The cells were then 
centrifuged for 10 minutes at 300 x g at room temperature. The supernatant was removed and the 
pellet resuspended in 2 mL of HT-29 culture media for passaging. For preparation of HT-29 IEC 
for challenge with cytokines or TLR agonists, the pellet was resuspended in RPMI 1640 after 
centrifugation. Cultures were grown and maintained in a humidified incubator (Thermo 
Corporation, Toronto) at 37°C and 5% CO2.  
 The IEC-6 primary rat cell line (ATCC CRL-1592) was maintained Dulbecco’s Modified 
Eagle Medium (DMEM) (Sigma, Canada) containing 10% FBS (Canada), 0.5 mg/ml gentamicin 
sulphate (Sigma, Canada), and 0.1 units/mL bovine insulin (Sigma, Canada).  They were 
passaged and incubated in the same manner as the HT-29 IEC. 
Bacterial Strains 
 Lactobacillus rhamnosus (R0011) and Lactobacillus helveticus R0052 were obtained 
from Institut Rosell Inc. (Montreal, Quebec) in the industrially packaged and lyophilized form 
(CFU/g). Bacteria were weighed aseptically, washed with PBS and centrifuged at 3000xg for 20 





CFU/mL in RPMI 1640, DMEM or PBS. This stock was used for addition to cell culture assays. 
For some assays, bacteria were heat-killed in a 70°C water bath for 60 minutes and a sample was 
streaked on de Man, Rogosa and Sharpe (MRS) ( Difco, BD, Canada)  plates and incubated at 
37 C to confirm death. For production of the broth, 400 μL of the bacterial suspension at 1x109 
cfu/mL was transferred into 19.6 mL of and incubated in a shaking incubator at 37°C, at a speed 
of 200-220 RPM for 17 hours. From this suspension, 1 mL was transferred to 9 mL of RPMI-
1640 or DMEM and incubated at 37°C, at a speed of 200-220 RPM for 23 hours. The pH of the 
broth was then measured and the corresponding control broth was adjusted to the same pH. The 
broths were then centrifuged at 3000g for 20 minutes filtered through a 0.22 um filtered 
(PROgene, Ultident Scientific, Canada) to remove bacteria.  After growth, bacterial strains or 
conditioned broth were stored in a refrigerator at 4°C.  
Challenge of HT-29s and IEC-6s with proinflammatory stimuli  
 Challenge of the HT-29 and IEC-6 IEC was carried out in 96 well plates at a 
concentration of 5x 10
5 
cells/mL diluted in the appropriate cell culture media. The plates were 
cultured and incubated overnight to allow a confluent IEC monolayer to form and cells were then 
treated with proinflammatory cytokines and bacteria or their products. In the case of LPS 
challenges, IEC were also incubated with 10% FBS, to allow optimal responses to this TLR4 
agonist. Titration of proinflammatory agonists and determination of the time needed to induce 
production of cytokines from HT-29 and IEC-6 IEC were performed in order to determine 
optimal concentrations and time points for supernatant collection (Table 2). Cells were incubated 
for 6 or 24 hours, depending on the time needed to induce specific cytokines, in a humidified 
incubator at 37°C and 5% CO2. Negative controls represent IEC and media only, and therefore 
constitutive IL-8 production, in the absence of proinflammatory stimuli. After incubation the 
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supernatants were collected and stored at -80°C until ELISAs were performed. All samples and 
challenges were carried out with technical triplicates.  
Table 2. Concentrations of proinflammatory cytokines and TLR agonists used to induce 
responses from IEC. 
Cytokine/ TLR Agonist Concentration Product 
Human TNF-α 50 ng/mL Peprotech 
Human IL-1β 30 ng/mL Sigma 
Polyinosinic-polycytidylic acid 
(poly(I:C) 
40 μg/mL Sigma 
Flagellin 100 μg/mL Enzo Life Sciences 
LPS 20 ng/mL Sigma 
CpG oligodeoxynucleotide 0.1-10 μg/mL Imgenex 
Zymosan A(Yeast cell was extract) 100μg/mL  Sigma 
Murine TNF 100 ng/mL Biovision 
 
Animal Care and Diets 
Animal care protocols were approved by the Heath Canada Ottawa Animal Care Committee and 
by the UOIT Animal Care Committee. Treatment and housing was performed according to 
Canadian Council on Animal Care (CCAC) guidelines. The rats used in this study were 
Biobreeding (BB) weanling rats (aged 28-42 days).These rats were obtained and raised at Heath 
Canada’s Animal Resource Division facility. Feeding trials lasted 34 days, however, a week 
prior to the beginning of the trials, rats were fed control diets. In Trial 2, rats were fed 5% oat 
fibre, 5% wheat fibre or AIN-93G control diets (American Association of Cereal Chemists, 
USA). In Trial 3 rats were fed 5% oat fibre, 5% wheat fibre, 5% resistant starch or AIN-93G. 
The baseline diet for both trials was AIN-93G. However, one additional diet was added, 5% 
fructooligosaccharides (FOS) (Encore Technologies, USA), for which the control and baseline 
diet was Purina Chow 5001 (Purina Mills, Pembroke, ON). At the end of the trial rats were 
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euthanized using O2/CO2. Rats were then dissected and various tissues were flash frozen in RNA 
later (Invitrogen) and shipped to UOIT where they were stored at -80°C.  
Tissue Homogenization 
Tissues (colon, ileum, spleen, MLN) were removed from -80°C storage and quickly suspended 
in PBS containing 1% protease inhibitor cocktail (Sigma-Aldrich, USA) at 5mL/1g. They were 
then homogenized using the Tissuemiser (Fisher Scientific, USA) until homogeneous. The 
homogenate was then centrifuged (Eppendorf, 5415D) for 30 minutes at 16,100xg. The pellet 
was discarded and the supernatant was centrifuged twice more. The homogenized tissues were 
stored at -80°C until ELISAs were performed. 
ELISA for Cytokine and Antibody Quantification 
DuoSet ELISA kits for IL-4 (DY504), IL-6 (DY506), IL-10 (DY522), TGF-β1 (DY240), CINC-
1 (DY515), and IL-1β (DY501) were obtained from Research and Development (R&D) (USA). 
The ELISA kit for IL-8 was obtained from Invitrogen (San Diego, California), IL-2 (CRC0023) 
and TNF-α (KRC301) were obtained from Invitrogen . Antibody ELISA kits, for measurement 
of IgG1 and IgG2, were obtained from Bethyl labs. All steps were completed following 
manufacturer’s instructions. ELISAs were completed using Greiner full well or half well plates. 
Tetramethylbenzidine (TMB) (Sigma, Canada) was used as the substrate. A wavelength of 450 
nm was used to read the plates on a Synergy HTTR microplate reader using KC4 version 3.4 
software (Bio-tek Instrumentation, Nepean, ON).  
Viability Assays for in vitro Studies 
Viability of IEC (HT-29 and IEC-6), were monitored by both visual inspection and neutral red 
staining (Sigma) after incubation periods with bacteria and bacterial products. The protocol for 
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neutral red staining was carried out as described by Repetto et al. (2008) [42]. Briefly, after 
incubation of IEC (at a concentration of 5x10
5 
cells/mL) with proinflammatory inducers, bacteria 
or their products, supernatants were removed and a 1% (v/v) neutral red solution diluted in cell 
culture media was added to each well. The plate was then placed at 37°C for 2 hours. Thereafter 
supernatants were removed, the wells washed with cell culture media and the destain solution 
(50% ethanol, 49% water, 1% acetic acid) added. After addition of the destain solution the plate 
was placed on a shaker for approximately 20 minutes, then the destain solution was removed and 
placed in a 96 well ELISA plate. The absorbance (540 nm) was read using the Synergy HTTR 
microplate reader using KC4 version 3.4 software (Bio-tek Instrumentation, Nepean, ON).  
Statistical Analysis 
The data were analyzed using a one way ANOVA (with Bonferrroni post-hoc test), a 
Kruskal-Wallis test (with Dunn post-hoc test) or Student’s t-test using the Instat program. All 











Effects of Lactobacillus rhamnosus R0011 on Inflammatory Responses of Human Epithelial 
cells (IEC) 
Decreased production of IL-8 by HT-29s IEC when co-incubated with TNF-α or TLR agonists 
and L. rhamnosus R0011 
Original experiments were performed using both L. rhamnosus R0011 and L. helveticus 
R0052. However, L. rhamnosus R0011 was more efficient at decreasing proinflammatory 
cytokine production from TNF-α treated IEC. Therefore it was selected for further 
characterization. HT-29 IEC were co-incubated with either TNF-α, IL-1β, poly (I:C), flagellin or 
LPS and L. rhamnosus R0011, either viable or heat-killed, for 6 hours. There was a significant 
decrease in TNF-α induced IL-8 production by HT-29 IEC incubated with viable R0011 (Figure 
1). However, this was not observed when IL-1β was used as the proinflammatory stimulus 
(Figure 2), where L. rhamnosus R0011 did not induce a decrease in IL-8 production. A slight 
decrease in TLR agonist-induced IL-8 production was also observed when HT-29 IEC were 
incubated with viable R0011 and poly (I:C) (Figure 3), flagellin (Figure 4) or LPS (Figure 5), 
however this decrease was not significant.  
In contrast, heat-killed L. rhamnosus R0011 did not significantly down regulate IL-8 
production induced by any of the stimuli. However, a common pattern was observed between the 
effects of viable and heat-killed L. rhamnosus R0011 in that heat-killed L. rhamnosus R0011 
demonstrated the ability to decrease IL-8 production from HT-29 IEC, although their efficacy 
was low. Additional TLR agonists, zymosan A (TLR2) and CPG (TLR9), were incubated with 
HT-29 IEC in an attempt to induce IL-8 production, however, the HT-29 IEC were unresponsive 
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to both agonists.  IL-1β production was also examined from HT-29 IEC using various inducers; 
although there was no detection of IL-1β production. 
Decreased IL-8 production by HT-29 IEC pre-incubated with L. rhamnosus R0011and 
challenged with TNF-α, IL-1-β or TLR agonists 
 HT-29 IEC were pre-incubated with L. rhamnosus R0011 for 18 hours before a 6 hour 
challenge with the various proinflammatory inducers. As depicted in Figures 6 to 9 there was a 
greater degree of decrease in IL-8 production observed in comparison to concurrent addition of 
L. rhamnosus R0011 and proinflammatory stimuli with IEC. However, a decrease in HT-29 IEC 
cell viability was observed when treated with viable L. rhamnosus R0011 over the 24 hour 
incubation period (Table 3). Pre-incubation of HT-29 IEC with L. rhamnosus R0011 efficiently 
reduced IL-1β induced IL-8 production by HT-29 IEC (Table 4). Interestingly, the heat-killed L. 
rhamnosus R0011 appeared to increase IL-8 production, as well as CINC-1 production by from 
IEC-6 IEC relative to constitutive levels, suggesting that there is a proinflammatory effect of 
R0011 over long incubation periods.  
Inability of L. rhamnosus R0011 to decrease IL-8 production when HT-29 IEC are pre-incubated 
with TNF-α or TLR agonists 
 In an attempt to characterize L. rhamnosus R0011’s interaction with IEC, HT-29 IEC 
were incubated with TNF-α or TLR agonists for an hour before the addition of L. rhamnosus 
R0011, and then incubated for 5 hours before cytokine measurement (Table 5). L. rhahmnosus 
R0011 showed a diminished ability to reduce IL-8 production by HT-29 IEC when added after 




Decreased IP-10 production from HT-29 IEC when co-incubated with L. rhamnosus and TNF-α 
 HT-29 IEC were coincubated with TNF-α and L. rhamnosus R0011 for 24 hours in order 
to determine effects on IP-10 production.  Figure 10 illustrates that a decrease in IP-10 levels 
when HT-29 IEC were concurrently treated with L. rhamnosus R0011 and TNF-α.However this 
decrease was not significant. Unfortunately, production of IP-10 was low after 24 hours, which 
may have contributed to the lack of significance.   
Decreased CINC-1 production by IEC-6 IEC when co-incubated with L. rhamnosus and TNF-α 
or a TLR agonist  
 IEC-6 IEC were co-incubated with TNF-α and/or L. rhamnosus R0011 (viable or heat-
killed) for 6 hours. As observed in Figure 11, there was a significant decrease in TNF-α induced 
CINC-1 production when IEC-6 IEC were incubated with viable L. rhamnosus R0011 in 
comparison to the positive control. IEC-6s were also co-incubated with the TLR agonist; 
flagellin (Figure 12) and L. rhamnosus R0011 for 24 hours. Treatment of IEC-6s with viable L. 
rhamnosus R0011 alone also significantly increased TNF-α production after 6 hours (Figure 13). 
Similarly, treatment with the L. rhamnosus R0011 alone for 24 hours increased TGF-β 
production (Figure 14). Contrary to the effects observed on HT-29 IEC, IEC-6 IEC produced 
CINC-1 when incubated with the TLR agonist zymosan A (Table 6), and L. rhamnosus 
demonstrated to ability to decrease this TLR2 induced CINC-1 production (Table 7). However, 
similar to the effects observed on HT-29 IEC, IEC-6 IEC were unable to produce IL-1β or IL-6 





Impact of Dietary fibre on the Immune system of Rats 
Effect of prebiotic fibre diets on serum IgG1 and IgG2a levels in BB rats 
 Total levels of antibody isotypes IgG1 and IgG2a were quantified in the serum of BB rats 
from trials 2 and 3. In trial 2, wheat bran and oat bran fed rats had lower amounts of serum IgG2 
(Figure 15). However, there was no difference in serum IgG1 (Figure 16) levels between rats 
receiving different fibre diets. In trial 3 FOS-fed mice had increases in both serum IgG1 (Figure 
17) and IgG2a (Figure 18) levels, however, this increase was not statistically significant. Wheat 
bran, oat bran and resistant starch diets had no statistically significant effect on serum IgG1 
(Figure 19) or IgG2a (Figure 20) levels. However, an increase in serum IgG1 was observed in 
oat bran or wheat bran-fed rats.  
Effect of fibre diets on TGF-β production within the MLN of BB rats 
 Active and total TGF-β were quantified in the MLN. As depicted in Figure 21, there was 
a significant increase in active TGF-β in resistant starch fed rats, in comparison to rats receiving 
the AIN-93G control diets. There was no significant difference in total MLN TGF-β (Figure 22) 
concentrations between rats fed any of the diets.  
Effect of prebiotic fibre diets on cytokine production of selected systemic tissues of BB rats 
 Cytokine levels were analyzed in two systemic locations, the spleen and serum. In the 
serum, CINC-1 was quantified (Figure 23) and there were no significant differences between 
FOS-fed and Purina chow control-fed rats, or between any rats fed of the other dietary fibres and 
AIN-93G (Figure 24).   
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 In the spleen, for rats fed the FOS supplemented diets, active TGF-β (Figure 25), IL-6 
(Figure 25), CINC-1 (Figure 25), IL-4 (Figure 25), IL-10 (Figure 25) and total TGF-β (Figure 
26) were quantified. The only significant difference between FOS diet-fed and Purina chow-fed 
control rats was observed with active TGF-β (Figure 25). Splenic active TGF-β was lower in 
FOS fed rats in comparison to rats fed the control, Purina chow.  In rats fed oat bran, wheat bran 
and resistant starch, splenic active TGF-β (Figure 27), IL-4 (Figure 27), CINC-1 (Figure 27), IL-
6 (Figure 27), IL-10 (Figure 27), total TGF-β (Figure 28) and IL-2 (Figure 29) were quantified. 
There was no significance observed in the spleen concentrations of any of the tested cytokines.  
However increases in splenic total TGF-β (Figure 28) and IL-4 (Figure 27) in oat bran-fed rats 
were observed, which corresponded with a decrease in splenic CINC-1 levels (Figure 27). It is 
important to note that although significance cannot be determined for splenic IL-2 (Figure 29), 
due to most rats having IL-2 concentrations below the level of detection, there was a difference 
observed between AIN-93G or wheat and resistant starch diets. In the spleen, IL-10 was below 
the level of detection for rats fed any of the diets. 
Effect of fibre diets within the ileum of BB rats 
 Within the ileum, another mucosal tissue, cytokines quantified included active TGF-β 
(Figure 30), CINC-1 (Figure 30), IL-4 (Figure 30), total TGF-β (Figure 31) and IL-10 (Figure 
32) for rats fed FOS or Purina chow control diets. There were increases in ileal CINC-1, IL-10, 
active TGF-β and total TGF-β in FOS-fed rats in comparison to the rats fed Purina chow diet; 
however, they were not significant. No difference was observed in ileal IL-4 levels and IL-6 was 
below the level of detection. 
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 In rats fed wheat bran, oat bran or resistant starch the cytokines quantified were active 
TGF-β (Figure 33), IL-4 (Figure 33), CINC-1 (Figure 33), total TGF-β (Figure 34) IL-10 (Figure 
35) and IL-6 (Figure 36). Rats fed wheat bran had significantly higher ileal concentrations of 
active TGF-β, CINC-, IL-4 and IL-10 in comparison to resistant starch fed-rats. These cytokines 
were also up-regulated in oat bran-fed rats, in comparison to AIN-93G-fed rats, although no 
significance was observed between rats fed the supplemented diets and control. 
Effect of fibre diets within the colonic tissue of BB rats 
 Cytokine levels were quantified in the colon, a mucosal tissue. The cytokines quantified 
for rats fed FOS and Purina chow diets were active TGF-β (Figure 37), IL-4 (Figure 37), CINC-1 
(Figure 37), IL-10 (Figure 37), IL-6 (Figure 37) and total TGF-β (Figure 38). In FOS-fed rats, 
active TGF-β was significantly increased in comparison to rats fed the Purina chow diet. This 
corresponds with the decrease in colonic CINC-1 observed in rats fed FOS diets, although not 
significant.  
 The cytokines quantified for rats fed AIN-93G, wheat bran, oat bran and resistant starch 
were active TGF-β (Figure 39), IL-4 (Figure 39), CINC-1 (Figure 39), IL-10 (Figure 39), IL-6 
(Figure 39) and total TGF-β (Figure 40). In rats fed AIN-93G, wheat bran, oat bran or resistant 
starch supplemented diets, significant differences were observed in cytokine levels for oat bran-
fed rats. Oat bran-fed rats had significantly higher levels of colonic CINC-1 in comparison to 
resistant starch fed rats. Oat bran-fed rats also demonstrated significantly higher levels of colonic 
IL-6 and active TGF-β in comparison to AIN-93G fed rats. There is a definite effect in colon of 
rats fed oat bran diets, with higher colonic tissue concentrations of cytokines compared to rats 
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fed other diets. This pattern was further supported when considering the effects of the oat bran 




























Figure 1. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011and TNF-
α for 6 hours, shown as mean concentration in pg/mL ± SEM (n=7). There was a significant 
difference in IL-8 production from HT-29 IEC treated with TNF-α alone and TNF-α with viable 
L. rhamnosus R0011(p-value <0.01). Statistical analysis compared only TNF-α treated IECBars 
with different letters are significantly different from each other (as determined by ANOVA and 













































Figure 2. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011and IL-1β 















































Figure 3. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011and poly 

























































Figure 4. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011and 








































Figure 5. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011and LPS 



























































Figure 6. IL-8 production by HT-29 IEC after pre-incubation with L. rhamnosus R0011 for 18 
hours and subsequent addition of TNF-α for 6 hours, shown as mean concentration in pg/mL ± 
SEM (n=4). There was a statistical trend (p=0.1) observed in IL-8 production from HT-29 IEC 
between TNF-α alone and HT-29 IEC treated with viable or heat-killed L. rhamnosus R0011 and 
TNF-α (as determined by an ANOVA and Bonferroni post-hoc test). Statistical analysis 







































Figure 7. IL-8 production by HT-29 IEC after co-incubation with L. rhamnosus R0011 and poly 



























































Figure 8. IL-8 production by HT-29 IEC after pre-incubation with L. rhamnosus R0011for 18 
hours and subsequent addition of LPS for 6 hours, shown as mean concentration in pg/mL ± 
SEM (n=3). There was a statistical trend (p=0.066) observed in IL-8 production from HT-29 IEC 
between TNF-α alone and HT-29 IEC treated with viable or heat-killed L. rhamnosus R0011 and 
TNF-α. There was a significant difference in IL-8 production from HT-29 IEC treated with 
viable L. rhamnosus R0011 compared to those treated with heat-killed L. rhamnosus R0011, as 
measured by an ANOVA  (p<0.05). Statistical analysis compared IEC treated with LPS 
separately from controls. Bars with different letters are significantly different from each other (as 




















































Figure 9. IL-8 production by HT-29 IEC upon pre-incubation with L. rhamnosus R0011 for 18 
hours and subsequent addition of flagellin for 6 hours, shown as mean concentration in pg/mL ± 

















































Figure 10. IP-10 production by HT-29 IEC after co-incubation with L. rhamnosus R0011 and 



















































Figure 11. CINC-1 production by IEC-6 IEC after co-incubation with L. rhamnosus R0011 and 
TNF-α for 6 hours, shown as mean concentration in pg/mL ± SEM (n=4). There was a 
significant difference in IL-8 production from IEC-6 IEC treated with TNF-α alone and IEC-6 
IEC treated with viable L. rhamnosus R0011 and TNF-α  (p<0.05). Statistical analysis compared 
only TNF-α treated IEC. Bars with different letters are significantly different from each other (as 















































Figure 12. CINC-1 production by IEC-6 IEC after co-incubation with L. rhamnosus R0011 and 
















































Figure 13. TNF-α production by IEC-6 IEC after incubation with viable or heat killed  L. 
rhamnosus R0011 for 6 hours, shown as mean concentration in pg/mL ± SEM (n=3). TNF-α 





















































 Figure 14. Total TGF-β production by IEC-6 IEC after incubation  (in the absence of 
proinflammatory stimuli) with L. rhamnosus R0011 and for 24 hours, shown as mean 










































Figure 15. Quantification of IgG2a (pg/mL) within the serum of trial 2 rats. Rats were fed either 
AIN-93G alone or AIN-93G supplemented with 5% oat fibre or 5% wheat fibre. The bars 




































Figure 16. Quantification of IgG1 (pg/mL) within the serum of trial 2 rats. Rats were fed either 
AIN-93G alone or AIN-93G supplemented with 5% oat fibre or 5% wheat fibre. The bars 









































Figure 17. Quantification of IgG1 (pg/g) within the serum of trial 3 rats. Rats were fed either 
Purina chow alone or Purina chow supplemented with 5% FOS. The bars represent the mean ± 










































Figure 18. Quantification of IgG2a (pg/mL) within the serum of trial 3 rats. Rats were fed either 
Purina chow alone or Purina chow supplemented with 5% FOS. The bars represent the mean ± 







































Figure 19. Quantification of IgG1 (pg/mL) within the serum of trial 3 rats. Rats were fed either 
AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant 
starch. The bars represent the mean ± SEM (n=10-12). There was no significant effect of diet, as 
determined by an ANOVA.  








































Figure 20. Quantification of IgG2a (pg/mL) within the serum of trial 3 rats. Rats were fed either 
AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant 
starch. The bars represent the mean ± SEM (n=10-12). There was no significant effect of diet, as 







































Figure 21. Quantification of active TGF-β (pg/g) within the MLN. Rats were fed either AIN-93G 
alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The 
bars represent the mean ± SE (n=4-6). TGF-β was BLQ in the MLN with one AIN-93G and one 
wheat bran-fed rat. These rats were assigned a value of 0 pg/g. There was a significant difference 
observed between rats fed-resistant starch and AIN-93G control diets (p<0.01). Bars with 
different letters are significantly different from each other (as determined by a Kruskal-Wallis 










































Figure 22. Quantification of total (active+latent) TGF-β (pg/g) within the MLN. Rats were fed 
either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=4-6). There was no significant effect of 



































Figure 23. Quantification of CINC-1 (pg/mL) within the serum. Rats were fed either Purina 
chow alone or Purina chow supplemented with 5% FOS. The bars represent the mean ± SE 





































Figure 24.  Quantification of serum CINC-1 (pg/mL). Rats were fed either AIN-93G alone or 
AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 










































Figure 25. Quantification of CINC-1, IL-6, IL-4, IL-10 and active TGF-β (pg/g) within splenic 
tissue. Rats were fed either Purina chow alone or Purina chow supplemented with 5% FOS. The 
bars represent the mean ± SE (n=5-6). Both IL-4 and IL-10 cytokine levels were BLQ. There 
was no significance effect on CINC-1 and IL-6 levels between rats fed the different diets, as 
measured by a t-test. There was a significant difference in between rats fed Purina chow and rats 


















































Figure 26. Quantification of total TGF-β (pg/g) within the spleic tissue. Rats were fed either 
Purina chow or Purina chow supplemented with 5% FOS. The bars represent the mean ± SE 



































Figure 27. Quantification of CINC-1, IL-6, IL-4, IL-10 and active TGF-β (pg/g) within splenic 
tissue. Rats were fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% 
wheat fibre or 5% resistant starch. The bars represent the mean ± SE (n=5-6). IL-10 cytokine 
levels were BLQ. IL-4 was BLQ in the splenic tissue of one oat bran-fed rat. This rat was 
assigned a value of 0 pg/g. There was no significant effect of diet on any cytokine levels, as 














































Figure 28. Quantification of total (active+latent) TGF-β (pg/g) within splenic tissue. Rats were 
fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=5-6). There was no significant effect of 




























Figure 29. Quantification of IL-2 (pg/g) within splenic tissue. Rats were fed either AIN-93G 
alone or supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean and ± SE (n=5-6). Those rats that are 0 pg/g represent IL-2 in rats that were 
BLQ. There was no significant effect of diet, as determined by a Kruskal-Wallis test and Dunn 













Figure 30. Quantification of CINC-1, IL-6, IL-4 and active TGF-β (pg/g) within the ileal tissue. 
Rats were fed either Purina chow or Purina chow supplemented with 5% FOS. The bars 
represent the mean ± SE (n=5-6). IL-6 cytokine levels were BLQ. There was no significance 

















































Figure 31. Quantification of total (active+latent) TGF-β (pg/g) within the ileal tissue. Rats were 
fed either Purina chow or Purina chow supplemented with 5% FOS. The bars represent the mean 






































Figure 32. Quantification of IL-10 (pg/g) within the ileal tissue. Rats were fed either Purina 
chow or Purina chow supplemented with 5% FOS. The bars represent the mean ± SE (n=6). 
































Figure 33. Quantification of CINC-1, IL-4 and active TGF-β (pg/g) within ileal tissue. Rats were 
fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=4-8). There was a significant difference in 
CINC-1 levels between rats fed  5% wheat fibre and 5% resistant starch diets (p<0.01). IL-4 was 
BLQ in the ileal tissue for one AIN-93G and one resistant starch-fed rat. These rats were 
assigned a value of 0 pg/g.  There was a significant difference in IL-4 levels  observed between 
rats fed 5% wheat fibre and rats fed 5% resistant starch diets (p<0.01). Active TGF-β was BLQ 
in the ileal tissue of one AIN-93G and one resistant starch-fed rat. These rats were assigned a 
value of 0 pg/g. There were  significant differences observed between rats fed 5% wheat fibre 
and 5% resistant starch diets (p<0.01), 5% oat fibre and 5% resistant starch diets (p<0.05). Bars 
with different letters are significantly different from each other (as determined by a Kruskal-
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Figure 34. Quantification of total (active+latent) TGF-β (pg/g) within ileal tissue. Rats were fed 
either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=6-8). There was no significant effect of 




























Figure 35. Quantification of IL-10 (pg/g) within ileal tissue. Rats were fed either AIN-93G alone 
or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean ± SE (n=4-6). Those data points that were BLQ were assigned a value of 
0pg/g. There was significance observed between 5% wheat-fed rats and 5% resistant starch-fed 
rats (p<0.01). Bars with different letters are significantly different from each other (as 
determined by a Kruskal-Wallis test and Dunn post-hoc test). 
    
    
    
    
    
    










Figure 36. Quantification of IL-6 (pg/g) within ileal tissue. Rats were fed either AIN-93G alone 
or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% resistant starch. The bars 
represent the mean and ± SE (n=4-6). Data points that were BLQ were assigned a value of 0 
pg/g. There was no significance observed between rats fed different diets (as determined by a 












Figure 37. Quantification of CINC-1, IL-6, IL-4, IL-10 and active TGF-β (pg/g) in colonic 
tissue. Rats were fed either Purina chow or Purina chow supplemented with 5% FOS. The bars 
represent the mean ± SE (n=3-7). There was no significant difference in CINC-1, IL-6, IL-4 and 
IL-10 levels between rats fed different diets. There was a significant difference in active TGF-β 
between rats fed Purina chow and rats fed the 5% FOS diet (p<0.05). Bars with asterisks denote 













































Figure 38. Quantification of total (active + latent) TGF-β (pg/g) within colonic tissue. Rats were 
fed either Purina chow or Purina chow supplemented with 5% FOS. The bars represent the mean 




































Figure 39. Quantification of CINC-1, IL-6, IL-4, IL-10 active TGF-β, and IL-4 (pg/g) within 
colonic tissue. Rats were fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 
5% wheat fibre or 5% resistant starch. The bars represent the mean ± SE (n=3-8). There was a 
significant difference in CINC-1 levels  between rats fed 5% oat fibre and 5% resistant starch 
diets (p<0.05). There was a significant difference observed between rats fed 5% oat fibre and rats 
fed AIN-93G diets (p<0.01), 5% resistant starch and AIN-93G (p<0.01) and 5% oat fibre and 5% 
wheat fibre diets (p<0.05). There was no significant difference in IL-4 and IL-10 levels between 
rats fed different diets. There was a significant difference in active TGF-β levels between rats fed 
5% oat fibre and rats fed AIN-93G diets (p<0.05). Bars with different letters are significantly 
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Figure 40. Quantification of total (active+latent) TGF-β (pg/g) within colonic tissue. Rats were 
fed either AIN-93G alone or AIN-93G supplemented with 5% oat fibre, 5% wheat fibre or 5% 
resistant starch. The bars represent the mean ± SE (n=3-6). There was no significant effect of 



































Table 3. Viability of HT-29 IEC and IEC-6 IEC after incubation with L. rhamnosus R0011. 






) 0.20 (81%) 
Heat-killed R0011 0.19(102%) 0.23 (92%) 
Negative control 0.19 0.25 
IEC-6 IEC 
Viable R0011 0.035 (116%) 0.07 (116%) 
Heat-killed R0011 - - 
Negative control 0.03 0.06 
1
OD at 540nm 
2


















Table 4. IL-1β induced IL-8 production by HT-29 IEC pre-incubated with L. rhamnosus 
R0011 for 18 hours.  




Viable R0011+ IL-1β 565.88 
Heat-killed R0011+IL-1β 889.59 
Viable R0011 10.81 
Heat-killed R0011 37.367 
Negative Control 9.96 
1



































3 774.76 739.60 4.43 5.27 5.47 
IL-1β 382.89 445.10 303.93 4.43 5.27 5.27 
Poly::IC 433.34 467.48 417.87 3.94 3.39 5.04 
LPS
2 20.78 23.74 21.57 11.62 7.13 9.58 
Flagellin 41.56 60.56 38.45 4.43 5.27 5.47 
1
N of 1 
2




















Table 6. IL-8 and CINC-1 induction from HT-29 IEC and IEC-6 IEC, respectively, 
in response to zymosan A after 24 hours of incubation. 
Zymosan A Concentration
1








5 BLQ 979.27 
10 BLQ 1220.51 
20 BLQ 1326.67 
50 BLQ 1512.62 
100 BLQ 1632.14 
200 BLQ 1650.38 



















Table 7. CINC-1 induction from IEC-6 IEC when co-incubated with L. rhamnosus R0011  





 positive control 2827.32 
Viable R0011+zymosan A 1335.19 
Heat-killed R0011+zymosan A 3227.19 
Viable R0011 alone 176.04 
Heat-killed R0011 alone 884.00 
Negative control 521.07 
1


















Analysis of Anti-Inflammatory Effects of Lactobacillus Strains on Rat and Human IEC 
The term ‘probiotic’ in recent years has become a household term. However, many 
people do not truly know what a probiotic is, or the ways in which they confer health benefits. 
The current definition used by Health Canada and the World Health Organization (WHO) to 
define a probiotic is “live microorganisms which when administered in adequate amounts confer 
a health benefit to the host."  The health benefits attributed to probiotics include colonization 
resistance, enhancement of mucin production, preventing the binding of pathogens and, 
treatment of diarrhea [43]. The WHO definition stresses that a probiotic must be living in order 
to confer its health benefits within the host organism. However, probiotic strains that have been 
killed and administered to the host also have been observed to exhibit physiological effects [44]. 
In a study by Li et al. (2009), both heat-killed and viable L. rhamnosus GG demonstrated the 
ability to decrease CINC-1 in the liver and plasma of LPS-challenged rats [44]. Similarity, the 
results here demonstrate a decrease in proinflammatory cytokines produced by human and rat 
IEC when incubated with viable L. rhamnosus R0011 and proinflammatory inducers. In 
comparison, there was no significant decrease of proinflammatory cytokine production by human 
and rat IEC when incubated with proinflammatory inducers and heat-killed R001. However, the 
overall effect of heat-killed L. rhamnosus R0011 produced a similar pattern to that seen with 
viable L. rhamnosus R0011, as heat-killed R0011 decreased CINC-1 and IL-8 production by rat 
and human IEC, respectively, though the effect was not as marked as with the viable L. 
rhamnosus R0011. This pattern demonstrates some efficacy of heat-killed L. rhamnosus R0011 
to alter proinflammatory cytokine induction from IEC.  However, this pattern was not apparent 
when IEC were incubated with heat-killed L. rhamnosus R0011 for longer periods of time 
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(24hr), in the absence of a standard pro-inflammatory inducers. In fact, an increase in 
constitutive CINC-1 and IL-8 production by IEC was observed when incubated with heat-killed 
L. rhamnosus R0011 for 24 hours.  This could suggest that the heat-killed bacteria are unable to 
produce an immune altering bioactive factor produced by viable L. rhamnosus R0011. Therefore, 
exposure to PAMPS on heat-killed L. rhamnosus R0011 bacteria, over the incubation time, 
increases IEC proinflammatory output, which is not down-regulated, due to the absence of the 
bioactive factor. This, however, does not explain the effects of heat-killed L. rhamnosus on IEC 
during co-incubation studies. Perhaps, the decrease in IL-8 and CINC-1 observed during co-
incubation with proinflammatory inducers and heat-killed L. rhamnosus is due to a surface 
compound interacting with the IEC.  This surface compound could be loosely bound to the cell 
membrane, so a decrease in CINC-1 and IL-8 is observed when HT-29 or IEC-6 IEC is treated 
with heat-killed L. rhamnosus R0011.  Perhaps viable L. rhamnosus is able to produce more of 
this membrane factor, and so viable L. rhamnosus R0011 are more effective at decreasing 
proinflammatory cytokine production. In addition a loosely associated membrane factor could 
also be released into culture medium, which would account for effects observed with the cultured 
media of this strain. Pre-incubation of HT-29 and IEC-6 IEC with L. rhamnosus R0011down 
regulated IL-8 and CINC-1 production, respectively, more so than did co-incubation with L. 
rhamnosus R0011. Extended incubation times of viable L. rhamnosus R0011 with HT-29s 
seemed to have detrimental effects. Viability itself did not seem affected; however there was 
reduced IEC growth after 24 hours in comparison to control wells not containing viable L 
rhamnosus R0011. The lack of growth by HT-29 IEC could be due to the drop in pH of wells 
containing viable bacteria, due to the increase in lactic acid and SCFAs produced by viable L. 
rhamnosus R0011. Interestingly, Mariadason et al. (2001) demonstrated that butyrate caused 
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differentiation and apoptosis in Caco-2 IEC [45]. Butyrate has also been demonstrated to cause 
apoptosis in HT-29s [46]. However, butyrate has differential effects on colon cancer cells lines 
versus IEC in vivo.  While the HT-29 IEC cell line is a well-established model for study of 
human IEC, it is a colon cancer cell line, while the rat IEC-6 is primary cell line. This difference 
in response to butyrate might explain why the HT-29 IEC were affected by the presence of L. 
rhamnosus and the IEC-6 cell line was not.  
 Based on the numerous modes of action reported for probiotics, current evidence 
suggests their activity can differ greatly between genus, species and even strain of bacteria. This 
could explain why multistrain probiotics are often more effective at altering immunity, as more 
immune-related pathways would be affected [47]. While many probiotics have been 
demonstrated to alter the pathways involved with NF-κB-mediated signaling, some more novel 
pathways are being exposed. For example, Hӧrmannsperger et al. (2009) demonstrated that a 
strain of Lactobacillus casei induced posttranslational degradation of the chemokine IP-10 
(CXCL-10) by TNF-α-stimulated Mode-K cells (HEK293), but the expression and synthesis of 
IP-10 was not affected [48]. However, the results of the pre-incubation with proinflammatory 
stimuli suggest that this is not the way in which L. rhamnosus R0011 decreases IL-8 production, 
as no decrease in IL-8 was observed when HT-29s were first treated with TNF-α, followed by 
addition of viable L. rhamnosus R0011. 
The bacteria Lactobacillus rhamnosus GG has been studied with great intensity due to the 
associated claims of improved host health. It is, arguably, the most intensely studied probiotic 
strain to date. L. rhamnosus GG has demonstrated the ability to decrease chemokine expression, 
prevent the detrimental effects of E. coli O157:H7 on IEC, as well as prevent apoptosis in IEC. 
This probiotic confers its effects, in part, by blocking NF-κB activation [49]. Though L. 
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rhamnosus GG has been demonstrated to secrete bioactive immune altering peptides [50], the 
mechanisms behind its probiotic effects are still unclear.  Sánchez et al (2009) has developed a 
method for identifying proteins secreted from probiotic strains. Their approach involves growth 
of the Lactobacillus strain in MRS broth, then precipitating the proteins followed by analysis 
using tandem MS/MS [51]. From this approach, his group has identified novel proteins secreted 
by several Lactobacillus strains. Specifically, this study determined that Lactobacillus 
rhamnosus GG secreted a cell wall hydrolase and also glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). The cell wall hydrolase was linked with the ability of the strain to 
prevent damage to the epithelial cell layer, while the authors suggest GAPDH is involved in 
adhesion to intestinal receptors [52].  Using an alternative method, Yan et al. (2007) identified 
two proteins secreted by L. rhamnosus GG, which they termed p75 and p40. These proteins 
reduced damage in IEC caused by TNF- α and decreased TNF-α induced IEC apoptosis [53].  
There has been speculation that some probiotics also alter immune responses through a 
TLR2-mediated pathway. This has been demonstrated for a variety of different probiotic strains. 
Shimazu et al. (2012) used a strain of Lactobacillus jensenii, which down regulated 
proinflammatory cytokine production and NF-κB activation from porcine IEC stimulated with 
enterotoxigenic E. coli (ETEC) or LPS. These investigators later showed that the protective 
ability of Lactobacillus jensenii was partially TLR2 mediated [54]. Similarly, Ciorba et al. 
(2012) investigated the effects of the probiotic L. rhamnosus GG and its conditioned media on 
radiation damage in the gut. These investigators found that both the bacteria and its conditioned 
media protected from epithelial apoptosis, and also lead to improved crypt cell survival in wild 









) mice [55]. This demonstrates that 
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the bacterium is conferring its effects through a TLR2 mediated pathway. Similarly, secreted 
factors from probiotic strains have also shown the ability to interact with DCs. Hoarau et al. 
(2006) demonstrated that supernatants from Bifidobacterium breve caused DCs to mature and in 
doing so increased expression of CD83, CD86 and HLA-DR (human leukocyte antigen-DR) 
through a TLR2-dependent mechanism [56]. 
A key TLR2 agonist, located on the cell wall of gram positive bacteria, is lipoteichoic acid. 
Thus, if probiotic bacteria are exerting effects through the TLR2 pathway, it could be due to the 
presence of this TLR2 agonist in their cell wall. However, other evidence casts doubt on the role 
of TLR2 in anti-inflammatory effects of probiotics. A study by Claes et al. (2010) examined 
effects of knocking out a gene involved in the synthesis of lipoteichoic acid (resulting in loss of 
cell wall D-alanine esters) in L. rhamnosus GG. Wild-type (wt) L. rhamnosus GG had no anti-
inflammatory effect in mice with dextran sodium sulphate (DSS) induced colitis. In fact, wt L. 
rhamnosus GG increased the disease severity. However, the knockout strain of L. rhamnosus GG 
demonstrated the ability to decrease disease severity by increasing body weight (in 3% DSS 
treated mice) and decrease inflammation (in 1% DSS treated mice). This demonstrates that the 
anti-inflammatory effects of L. rhamnosus GG were not due to lipoteichoic acid [57].  
 Zymosan A, a TLR2 agonist, demonstrated the ability to decrease CINC-1 production 
from IEC-6s. In comparison, HT-29s were unresponsive to zymosan A, producing no IL-8 upon 
stimulation. The discrepancy in the response to zymosan between HT-29s and IEC-6s could be 
due to differential expression of the TLR2 receptor on the apical surface between cell lines 
and/or species. Interestingly, L. rhamnosus R0011 decreased production of CINC-1 from 
zymosan A treated IEC-6s. Although TLR stimulation typically leads to NF-κB activation, this 
effect of zymosan is interesting, due to the fact that some probiotics have demonstrated the 
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ability to decrease proinflammatory responses through the TLR2 receptor.  This further suggests 
that the mechanism used by L. rhamnosus R0011 to decrease CINC-1 production by IEC-6 and 
is not TLR2 mediated. 
 Neither IEC-6s nor the HT-29 IEC responded to CpG DNA, a TLR 9 agonist. This lack 
of response to CpG DNA has been documented previously in bronchial epithelial cells, where 
IL-8 was only induced when CpG acted synergistically with IL-1β [58]. Logically, the 
abundance of CpG within the gut would be astronomical; therefore perhaps IEC are desensitized 
to this agonist or TLR9 expression is low, to prevent constant inflammation in the gut.  
 An increase in TNF-α production was observed from IEC-6s after 24 hours of incubation 
with viable L. rhamnosus R0011. This may suggest that this bacterium has proinflammatory 
effects on IEC in the absence of other stimuli. Production of TNF-α from mammalian cells has 
been observed with several probiotic strains. For example, strains of the probiotic Bifidobacteria 
have demonstrated the ability to significantly increase TNF-α and IL-6 production by 
macrophages [59]. This method of immune alteration, in an in vivo model, would be effective in 
increasing host responses to pathogens, by recruiting other immune cells, and would be most 
effective if the bacterium or its by products were to cross into the PP. Interestingly, a decrease in 
TGF-β production was observed in IEC-6s treated with heat-killed IEC-6s, which corresponds 
with the increases in CINC-1 production observed after 24 hours of incubation with L. 
rhamnosus R0011.  
The effects of L. rhamnosus R0011 on cytokine production from HT-29 and IEC-6 IEC 
could be due to adherence to IEC, as demonstrated by Wallace et al. [40]. The anti-inflammatory 
effects may not only due to a secreted factor, but, also the direct interaction between bacteria and 
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IEC. However, a study has demonstrated that there is no link between probiotic efficacy and 
adhesion properties [60], giving further weight to evidence suggesting that at least certain strains 
of probiotics exert their effects through secreted factors.  
Effects of Prebiotics on Mucosal and Systemic Immunity 
 The use of the term prebiotic has become more popular in recent history. Prebiotics are 
claimed to reduce the incidence of strokes, diabetes, obesity, etc. [61]. One of these claimed 
effects is the alteration of the immune system, in a beneficial sense. However, the current 
definition of a prebiotic does not include effects on the immune system. This is partially due to 
the unknown mechanisms through which prebiotics confer their effects on the host. The effects 
of prebiotics must be defined in order to better understand the mechanisms in which they act, to 
validate claims of their health benefits, and to administer them more effectively. Previously, 
dietary fibres have demonstrated the ability to increase CD4
+
 T cell numbers in the MLN, 
increase IgA secretion in cecum, and increase the number of PPs, to provide as a few examples 
[59]. The results here however, demonstrate a novel aspect of dietary fibre, not demonstrated 
previously.  
Dietary FOS alters systemic immune parameters 
 The spleen was investigated for effects of dietary fibre on systemic immunity. This tissue 
has a major role in the mammalian immune system. It is a secondary lymphoid tissue that 
harbours vast amounts of both mature and immature T and B cells. It is a site a where antigens 
meet immature T and B cells and activation and maturation of these cells occurs. Thus, a great 
amount of immunoglobulin and cytokine production occurs in the spleen [62]. These functions 
make the spleen a tissue of interest for investigating diet-based changes in immune activity. 
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Interestingly, FOS-fed rats did have a change in active TGF-β levels in the spleen. TGF-β 
concentrations decreased in comparison to rats fed the corresponding control diet, Purina chow. 
The decrease in TGF-β levels could be indicating that FOS has a proinflammatory systemic 
effect, reflected in lower levels of this regulatory cytokine. Previous studies have demonstrated 
that FOS can have proinflammatory qualities in the spleen. In a series of experiments by 
Benyacoub et al. (2008) it was demonstrated that a FOS-supplemented diet increased 
proinflammatory cytokine output (IL-12, INF-γ and TNF-α) from mouse splenocytes challenged 
with LPS. This study also demonstrated the efficacy of using FOS as an adjuvant for a 
salmonella vaccine, where these proinflammatory properties could be an advantage [63]. 
Currently, there are patents for using FOS as an adjuvant.  
 There were no significant effects of wheat bran, oat bran and resistant starch 
supplemented diets on the spleen with respect to cytokine concentrations in this study. There is 
very little research to date which delves into the effect of these specific fibres on systemic 
immunity. Most prebiotic fibre research focuses on the effects of inulin and FOS. However, a 
study by Yamazak et al. (2008) did examine the effects of wheat bran extracts on peripheral 
blood mononuclear cells from human blood. This study demonstrated that that the wheat fibre by 
its self (no fermentation) increased production of IL-10 and inhibited Concanavalin A (Con-A)-
induced production of IL-5, IL-13 and INF-γ. The induction of IL-10 was TLR4 dependent, 
indicating that wheat contains some type of LPS-mimicking compound [64]. Therefore SCFA 





Wheat bran, oat bran, resistant starch and FOS alter mucosal immune parameters 
 The dietary fibres used in the present study demonstrated the ability to alter immune 
parameters at a mucosal level, with fibre-dependent differences observed with respect to control 
diets or between different fibre-supplemented diets. Mucosal tissues are those that provide a 
barrier for the microbiota, and so were a key location examined for effects on the immune 
system. The mucosal tissues investigated were the ileum, colon and MLN. The ileum is the lower 
portion of the small intestine, the colon is the large intestine and the MLN is a lymph node, 
responsible for draining the MALT [65].  Appendix 1 depicts the layout of the GI tract.   
The MLN is a T cell and B cell rich node allowing sampling of antigen from the gut. This 
is a key location for T and B cells to undergo activation and proliferation once they have 
encountered antigen within the gut [66]. The MLN also serves as a key location to “firewall” gut 
bacteria, using sIgA to prevent further translocation of commensals from the MLN into systemic 
locations [65]. Changes in T cell or APC activity as reflected by the MLN cytokine profile can 
thus serve as a useful indicator of potential effects of dietary fibre on the mucosal immune 
system. Within the MLN, the resistant starch diet significantly increased production of active 
TGF-β in comparison to all other diets and control. This suggests that resistant starch is inducing 
an anti-inflammatory effect in this tissue, an action that could possibly translate into increased 
Treg cell maturation [67]. Effects of a resistant starch-supplemented diet on mucosal immunity 
and specifically on the MLN have been previously explored. Resistant starch has demonstrated 




 ratio in the MLN [68]. This effect could 
correspond with an increase in TGF-β, similar to the observations outlined here with resistant 
starch-fed rats. In the same study, the authors documented increased IL-4 production from MLN 
lymphocytes when stimulated with Con-A. In a study by Bassaganya-Riera et al. (2011) it was 
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demonstrated that resistant starch could alleviate the symptoms associated with inflammatory 
bowel disease in IL-10 deficient mice. A resistant starch-supplemented diet decreased INF-γ 
production by CD4
+
 T cells, increased IL-10 expression in the spleen, and also increased PPAR-
γ expression in the colon [69].  The results here demonstrate the effects of resistant starch diet in 
rats at baseline levels, and have demonstrated the ability to significantly alter cytokine levels in 
the MLN. It would suggest that in a proinflammatory state, resistant starch might have the 
potential to counter inflammatory effects by increasing production of regulatory cytokines such 
as IL-10 and TGF-β. 
The ileum is often associated with changes in gut immunity or homeostatic mechanisms. 
This is mostly due to the fact that surrounding the ileum are the PPs [66]. The PPs contain many 
germinal centres, up to 250, in which T and B cells are located, waiting for antigen presentation 
from antigen presenting cells or direct contact with bacteria and/or their secreted products [70] 
[71]. The PPs have similar functions as the MLN, except on a smaller scale. Rats fed the wheat 
bran supplemented diet had significant alterations in ileal cytokine profiles in comparison to rats 
fed the AIN-93G control diet and the other fibre diets. Significant increases in ileal 
concentrations of active TGF-β, CINC-1 and IL-4 were observed between rats fed wheat bran in 
comparison to those fed the resistant starch supplemented diets. 
Collaborators have demonstrated that resistant starch diets in rats decrease bacterial load 
and diversity within the gut in comparison to wheat and oat diets, as well as in comparison to the 
AIN-93G control diet (personal communication, M. Kalmokoff). This could lead to less 
fermentation and decreased production of SCFAs. On the other hand, wheat bran significantly 
increases bacterial load and diversity [9] as well as increasing production of SCFA relative to 
control non-prebiotic diets [72]. The decrease in microbiota diversity and bacterial load 
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associated with resistant starch could explain the decrease in cytokines within the ileum observed 
in resistant starch-fed rats, while the increase with wheat bran can be attributed to the greater 
microbial load and microbiota diversity induced by this fibre. Although microbial load and 
diversity were measured in the colon, the effects still might have been great in the ileum. It does 
not, however, explain the effects of the resistant starch diet on the MLN of rats. Alternatively, 
wheat bran contains many food antigens, which could lead to an immune inducing effect and 
potentially a proinflammatory response. Related to this observation is the study by Yamazaki et 
al. (2008), which demonstrated the presence of a LPS-like molecule in wheat, which interacts 
with TLR4. Activation of TLR4 in the gut could lead to a proinflammatory response, as observed 
by an increase in CINC-1 [64].  
The increase in IL-10 and active TGF-β levels in the ileum of rats fed wheat bran diets 
indicates that there is possibly an anti-inflammatory effect or response induced by the dietary 
fibre. The increase in ileal CINC-1 levels in rats fed wheat bran-supplemented diet could be due 
to homeostatic mechanisms and may not represent a proinflammatory response.  The increase 
could also be linked to the increase in bacterial load observed previously with wheat bran fed 
mice [9]. If this were the case, more bacterial antigen and proinflammatory agonists would be 
present in the ileum, potentially leading to a proinflammatory response, and an increase in 
CINC-1.  
In rats, between the ileum and colon, lies the cecum. The most fermentation occurs in this 
tissue, hence rats are known as ‘cecal fermenters’ [73]. Therefore it is possible that SCFA are 
produced from cecal fermentation can enter the colon and have immune altering effects at this 
location. The colon contains the most bacteria of all locations along the GI tract, suggesting that 
there would be considerable interaction between this tissue and the microbiota [74]. Rats fed the 
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oat-supplemented diet had higher colonic tissue levels of active TGF-β, IL-6, IL-10 and CINC-1 
in comparison to the control, AIN-93G diet. Similarly, Metzler-Zebeli et al. (2012) found that a 
β-glucan diet increased the production of colonic IL-6 in pigs. The investigators attributed this 
increase in colonic IL-6 to the production of butyrate within the colon by the microbiota [75]. 
Interestingly, the study by Abnous et al. (2009) observed an increase in diversity and quantity of 
the microbiota in rats fed not only a wheat diet, but also an oat bran diet. As with the increase in 
diversity in wheat bran-fed rats, the difference in cytokine profiles in oat bran-fed rats could be 
attributed to this alteration in microbiota and greater production of SCFAs. The increase in 
colonic tissue levels of TGF-β and IL-10 would suggest that IL-6 has an anti-inflammatory role 
in this context, potentially leading to B and T cell maturation and antibody class switching, 
activities supported by IL-6 [76]. 
Similar to oat bran-fed rats, resistant starch-fed rats also had alterations in colonic 
cytokine levels in comparison to the AIN-93G control diet-fed rats. Increases were observed in 
colonic levels of IL-4, IL-10, IL-6 and TGF-β for resistant starch-fed rats in comparison to those 
receiving the control diet. Interestingly, the resistant starch diet increased these cytokine 
parameters without increasing CINC-1 production in comparison to control. In contrast oat bran-
fed rats an increase in CINC-1. This suggests that perhaps wheat bran acts through a separate 
pathway than resistant starch. However, the proinflammatory effect may be needed in order to 
induce downstream effects in immunity. 
The only statistically significant difference in cytokine levels observed between the FOS-
fed rats and the Purina chow control-fed rats was in active TGF-β in the colon. This increase in 
colonic active TGF-β levels corresponded with a decrease in CINC-1 levels; however, this 
difference was not statistically significant. This suggests that within the colon, FOS may have an 
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anti-inflammatory effect. This indication has been demonstrated previously. Inulin, another type 
of fructan, has demonstrated the ability to lower disease severity and inflammation in 
chemically-induced colitis in rats. This anti-inflammatory effect corresponds with an increase in 
LAB numbers in the cecum as well as in production of colonic lactate and butyrate [77].  A 
similar study by Hoentjen et al. (2005) demonstrated that the combination of inulin and FOS 
(Synergy 1) decreased the colitis disease severity score in genetically predisposed (HLA-B27) 
‘colitis’ mice. Similarly they observed increases in Lactobacillus and Bifidobacerium numbers in 
the cecum. Most importantly, they also found that a Synergy 1-supplemented diet decreased 
cecal IL-1β and increased cecal TGF-β [78]. These findings show a similar pattern to the 
decrease in colonic CINC-1 and increase in colonic TGF-β observed in our study. 
There was a general pattern for cytokine production profiles in FOS-fed rats within the 
ileum. Greater production of most cytokines in ileal tissue was observed in FOS-fed rats 
compared to rats receiving the Purina chow control diet; however these differences were not 
statistically significant. The reason these cytokines measurements did not attain statistical 
significance could reflect certain properties of the background diet, Purina chow. Purina chow is 
a commonly used food source for experimental rodents. However, the composition is somewhat 
variable (changes between batches). In addition, Purina chow contains soy products, including 
flavonoids and estradiols. These compounds have been document to modify immune responses 
[79]. Therefore, Purina chow could potentially be masking immune alterations of FOS, which 
might otherwise be more evident, as observed with the other dietary fibres. In comparison the 
AIN-93G control has a known and precisely defined amount of carbohydrates, proteins, fat, 
vitamins, minerals [80].  AIN-93G also has a smaller amount of flavonoids and estradiols, which 
makes it more applicable to nutritional immunology studies. Further study of the effects of FOS 
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using the AIN-93G control diet would therefore be potentially valuable in delineating the true 
extent of its effects on mucosal and systemic immune parameters.  
Overall, based on the results shown here, FOS seems to have some anti-inflammatory 
effects at the mucosal level, while however showing a proinflammatory effect at the systemic 
level. Previous research has demonstrated that this dichotomy in fact could be accurate. Wheat, 
oat and resistant starch, in comparison to control, have no effects systemically, but have very 
significant effects at the mucosal level. The results here seem to suggest that specific dietary 
fibres can target different gastrointestinal locations, depending on their fermentability and 
capacity to influence microbiota changes and diversity in the gastrointestinal tract.  
However, the effects observed with the prebiotic diets may not all be due to bacterial 
fermentation and the resulting SCFA production. In a study by Zenhom et al. (2011) the effects 
of prebiotic fibres themselves, without the fermentation of bacteria was investigated. Prebiotics 
alone (oligosaccharides, α3-sialyllactrose and FOS) showed potential anti-inflammatory activity 
by reducing IL-12, IL-8, TNF-α and NF-κB expression as well as increased PPAR-γ expression 
in the Caco-2 human IEC cell line [81]. When prebiotics are ingested in combination with certain 
probiotic strains immune alterations have also been reported to occur.  Roller et al. (2004) have 
demonstrated in rats that when prebiotics (inulin and FOS) and probiotics (L. rhamnosus and B. 
lactis) are combined they increased production of IgA in the ileum and decreased oxidative burst 
activity in blood neutrophil. However, prebiotics by themselves did not have these effects; 
instead they enhanced production of IL-10 in the PP and IgA in the cecum. This type of evidence 
suggests that combined delivery of probiotics and prebiotics has greater potential to influence the 
host immune system than delivery of either alone [82]. However, much remains to be learned 




 Future studies could examine the effect of L. rhamnosus R0011 on NF-κB specific cell 
pathways. The use of a cell line expressing specific TLR receptors and NF-κB activation reporter 
systems would be of use in this context. This approach would demonstrate which TLRs are 
essential for the effects observed with L. rhamnosus R0011, as well as confirm that NF-κB is 
indeed being down regulated in L. rhamnosus treated IEC. It would also be of interest to 
investigate whether the increase in TNF-α observed with viable L. rhamnosus R0011-treated 
IEC-6s is NF-κB dependent, by using NF-κB specific inhibitors. Certain strains of bacteria can 
influence the expression of TLRs by IEC and thus one could investigate whether L. rhamnosus 
R0011 influences TLR expression on HT-29s, IEC-6s, and on other cell types where TLR 
expression is important, such as macrophages and dendritic cells. 
In addition, recent preliminary data suggests that L. rhamnosus R0011may release the 
neurotransmitter gamma-aminobutyric acid (GABA). Investigating the possible communication 
between bacteria and parasites within the gut could be of value as this is an understudied area of 
research, and may provide insight into interactions between the gut microbiota and parasites, and 
potentially into novel anti-parasite strategies. Lastly, investigating the effects of dietary fibre in 
challenged models (ex. immunized rats) could provide more information about dietary effects on 
immunity. Specifically, immunization would activate the typical events in an immune response, 
and so provide a useful approach to more fully delineate the effects of dietary fibre on immunity 






The L. rhamnosus R0011 strain has demonstrated the ability to decrease proinflammatory 
indicators to a large variety of selected proinflammatory inducers that would typically be 
encountered by the immune system. The current data suggests that this decrease in 
proinflammatory cytokine production is not due to post-translational degradation, and may 
reflect blocking of a cellular pathway upstream of translation.  
 In addition, the results shown in this thesis demonstrate that the effect of different dietary 
fibres is tissue specific. The data suggests that dietary resistant starch affects cytokine profiles in 
the MLN, wheat fibre affects cytokine profiles in the ileum and oat affects cytokine profiles in 
the colon.  However, the potential overall health benefits of this alteration in cytokine levels 
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